Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors

PURPOSE: Paclitaxel, ifosfamide, and cisplatin (TIP) achieved complete responses (CRs) in two thirds of patients with advanced germ cell tumors (GCTs) who relapsed after first-line chemotherapy with cisplatin and etoposide with or without bleomycin. We tested the efficacy of first-line TIP in patien...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Oncol
Main Authors: Feldman, Darren R., Hu, James, Dorff, Tanya B., Lim, Kristina, Patil, Sujata, Woo, Kaitlin M., Carousso, Maryann, Hughes, Amanda, Sheinfeld, Joel, Bains, Manjit, Daneshmand, Siamak, Ketchens, Charlene, Bajorin, Dean F., Bosl, George J., Quinn, David I., Motzer, Robert J.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2016
Teme:
ORIGINAL REPORTS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5320896/
https://ncbi.nlm.nih.gov/pubmed/27185842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.66.7899
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki